ConMed has agreed to acquire the US-based medical device company SurgiQuest for $265m.

SurgiQuest is a privately-held venture-backed firm, which develops, manufactures and markets access technologies for minimally invasive surgery.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company’s AirSeal system access management technology is used in laparoscopic and robotic procedures.

"Revitalising the Advanced Surgical business is a key element of our general surgery strategy, and this transformative acquisition uniquely bolsters the progress we have made."

AirSeal, which has been used in over 250,000 procedures globally, features a valve-free trocar with continuous pressure sensing and an insufflator and smoke evacuator.

Conmed expects the acquisition to add $55m to $60m to its revenue in fiscal year 2016. Net cost savings will approximate $15m a year.

The transaction, which is subject to US regulatory approval, is expected to complete in the first quarter of 2016.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

As part of the acquisition, SurgiQuest founder and CEO Kurt Azarbarzin will join Conmed as chief technology officer of the advanced surgical business.

Conmed president and CEO Curt Hart said: "Revitalising the Advanced Surgical business is a key element of our general surgery strategy, and this transformative acquisition uniquely bolsters the progress we have made.

"The AirSeal system is a highly differentiated technology which is fast becoming the standard of care in laparoscopic and robotic surgery where it delivers benefits for the patient, the surgeon, and the hospital."

Conmed provides surgical devices and equipment for minimally invasive procedures. The company’s products are used in various specialities, including orthopedics, general surgery, gynecology, neurosurgery and gastroenterology.